Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.360
+0.170 (7.76%)
Mar 31, 2026, 4:00 PM EDT - Market closed
Acumen Pharmaceuticals Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$7.75
Upside
+228.39%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +238.98% | Mar 26, 2026 |
| BTIG | BTIG | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +238.98% | Mar 16, 2026 |
| BTIG | BTIG | Strong Buy Maintains $4 → $7 | Strong Buy | Maintains | $4 → $7 | +196.61% | Jan 27, 2026 |
| B of A Securities | B of A Securities | Strong Buy Maintains $9 → $8 | Strong Buy | Maintains | $9 → $8 | +238.98% | Nov 18, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $10 → $9 | Strong Buy | Maintains | $10 → $9 | +281.36% | Aug 25, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +69.49% | Jun 17, 2025 |
| UBS | UBS | Strong Buy Maintains $6 → $4 | Strong Buy | Maintains | $6 → $4 | +69.49% | Mar 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $11 | Strong Buy | Maintains | $15 → $11 | +366.10% | Mar 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +535.59% | Nov 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +535.59% | Oct 3, 2024 |
| UBS | UBS | Strong Buy Maintains $14 → $6 | Strong Buy | Maintains | $14 → $6 | +154.24% | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +535.59% | Aug 14, 2024 |
| Citigroup | Citigroup | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +196.61% | Jul 25, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +535.59% | May 15, 2024 |
| UBS | UBS | Strong Buy Maintains $15 → $14 | Strong Buy | Maintains | $15 → $14 | +493.22% | Mar 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +535.59% | Mar 27, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.